These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35427062)

  • 1. Retraction: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis
    Fisher L
    RSC Adv; 2021 Feb; 11(11):6254. PubMed ID: 35427062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted Article: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis
    Lu X; Chen F; Yuan D; He X; Liu X; Zi Y; Lu Y
    RSC Adv; 2019 Nov; 9(64):37642-37651. PubMed ID: 35542268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
    Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
    Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4.
    Zhong XL; Wang L; Yan X; Yang XK; Xiu H; Zhao M; Wang XN; Liu JX
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2955-2964. PubMed ID: 32271413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
    Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.
    Li RK; Gao J; Guo LH; Huang GQ; Luo WH
    Cancer Gene Ther; 2017 Jul; 24(7):309-315. PubMed ID: 28731027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
    Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
    Tao L; Wu YQ; Zhang SP
    Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-150 modulates cisplatin chemosensitivity and invasiveness of muscle-invasive bladder cancer cells via targeting PDCD4 in vitro.
    Lei Y; Hu X; Li B; Peng M; Tong S; Zu X; Wang Z; Qi L; Chen M
    Med Sci Monit; 2014 Oct; 20():1850-7. PubMed ID: 25287716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b.
    Fan Y; Sheng W; Meng Y; Cao Y; Li R
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):393-407. PubMed ID: 31913710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
    Yao W; Guo P; Mu Q; Wang Y
    Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
    [No Abstract]   [Full Text] [Related]  

  • 12. miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin.
    Zhen Y; Fang W; Zhao M; Luo R; Liu Y; Fu Q; Chen Y; Cheng C; Zhang Y; Liu Z
    Oncogene; 2017 Jan; 36(2):275-285. PubMed ID: 27270423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth.
    Cao LQ; Yang XW; Chen YB; Zhang DW; Jiang XF; Xue P
    Mol Cancer; 2019 Oct; 18(1):148. PubMed ID: 31656200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis.
    Ji C; Hu J; Wang X; Zheng W; Deng X; Song H; Yu Y; Luo Q; Hua K; Zhou X; Fang L
    Aging (Albany NY); 2021 Mar; 13(7):9627-9645. PubMed ID: 33744861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1.
    Cai X; Qu L; Yang J; Xu J; Sun L; Wei X; Qu X; Bai T; Guo Z; Zhu Y
    Cancer Med; 2020 Aug; 9(16):6009-6019. PubMed ID: 32627968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of miR-103a-3p suppresses lipopolysaccharide-induced sepsis and liver injury by regulating FBXW7 expression.
    Zhou YP; Xia Q
    Cell Biol Int; 2020 Sep; 44(9):1798-1810. PubMed ID: 32369227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-103a-3p potentiates chemoresistance to cisplatin in non-small cell lung carcinoma by targeting neurofibromatosis 1.
    Zhu H; Yang J; Yang S
    Exp Ther Med; 2020 Mar; 19(3):1797-1805. PubMed ID: 32104235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.
    Fu WF; Chen WB; Dai L; Yang GP; Jiang ZY; Pan L; Zhao J; Chen G
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2565-72. PubMed ID: 27383306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
    Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
    Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis [Retraction].
    Cancer Manag Res; 2022; 14():2105-2106. PubMed ID: 35769227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.